Cargando…
The Antihypertensive Drug Nifedipine Modulates the Metabolism of Chondrocytes and Human Bone Marrow-Derived Mesenchymal Stem Cells
Aging is associated with the development of various chronic diseases, in which both cardiovascular disorders and osteoarthritis are dominant. Currently, there is no effective treatment for osteoarthritis, whereas hypertension is often treated with L-type voltage-operated calcium channel blocking dru...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857108/ https://www.ncbi.nlm.nih.gov/pubmed/31781032 http://dx.doi.org/10.3389/fendo.2019.00756 |
_version_ | 1783470698075783168 |
---|---|
author | Uzieliene, Ilona Bernotiene, Eiva Rakauskiene, Greta Denkovskij, Jaroslav Bagdonas, Edvardas Mackiewicz, Zygmunt Porvaneckas, Narunas Kvederas, Giedrius Mobasheri, Ali |
author_facet | Uzieliene, Ilona Bernotiene, Eiva Rakauskiene, Greta Denkovskij, Jaroslav Bagdonas, Edvardas Mackiewicz, Zygmunt Porvaneckas, Narunas Kvederas, Giedrius Mobasheri, Ali |
author_sort | Uzieliene, Ilona |
collection | PubMed |
description | Aging is associated with the development of various chronic diseases, in which both cardiovascular disorders and osteoarthritis are dominant. Currently, there is no effective treatment for osteoarthritis, whereas hypertension is often treated with L-type voltage-operated calcium channel blocking drugs, nifedipine being among the most classical ones. Although nifedipine together with other L-type voltage-operated calcium channel inhibitors plays an important role in controlling hypertension, there are unresolved questions concerning its possible effect on cartilage tissue homeostasis and the development of osteoarthritis. The aim of this study was to analyse the effects of nifedipine on metabolic processes in human chondrocytes and bone marrow mesenchymal stem cells. To better understand whether the metabolic effects are mediated specifically through L-type voltage-operated calcium channel, effects of the agonist BayK8644 were analyzed in parallel. Nifedipine downregulated and mitochondrial respiration and ATP production in both cell types. Analysis of cartilage explants by electron microscopy also suggested that a small number of chondrocyte mitochondria's lose their activity in response to nifedipine. Conversely, nifedipine enhanced glycolytic capacity in chondrocytes, suggesting that these cells have the capacity to switch from oxidative phosphorylation to glycolysis and alter their metabolic activity in response to L-type voltage-operated calcium channel inhibition. Such a metabolic switch was not observed in bone marrow mesenchymal stem cells. Nitric oxide activity was upregulated by nifedipine in bone marrow mesenchymal stem cells and particularly in chondrocytes, implying its involvement in the effects of nifedipine on metabolism in both tested cell types. Furthermore, stimulation with nifedipine resulted in elevated production of collagen type II and glycosaminoglycans in micromass cultures under chondrogenic conditions. Taken together, we conclude that the antihypertensive drug nifedipine inhibits mitochondrial respiration in both chondrocytes and bone marrow mesenchymal stem cells and that these effects may be associated with the increased nitric oxide accumulation and pro-inflammatory activity. Nifedipine had positive effects on the production of collagen type II and proteoglycans in both cell types, implying potentially beneficial anabolic responses in articular cartilage. These results highlight a potential link between antihypertensive drugs and cartilage health. |
format | Online Article Text |
id | pubmed-6857108 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-68571082019-11-28 The Antihypertensive Drug Nifedipine Modulates the Metabolism of Chondrocytes and Human Bone Marrow-Derived Mesenchymal Stem Cells Uzieliene, Ilona Bernotiene, Eiva Rakauskiene, Greta Denkovskij, Jaroslav Bagdonas, Edvardas Mackiewicz, Zygmunt Porvaneckas, Narunas Kvederas, Giedrius Mobasheri, Ali Front Endocrinol (Lausanne) Endocrinology Aging is associated with the development of various chronic diseases, in which both cardiovascular disorders and osteoarthritis are dominant. Currently, there is no effective treatment for osteoarthritis, whereas hypertension is often treated with L-type voltage-operated calcium channel blocking drugs, nifedipine being among the most classical ones. Although nifedipine together with other L-type voltage-operated calcium channel inhibitors plays an important role in controlling hypertension, there are unresolved questions concerning its possible effect on cartilage tissue homeostasis and the development of osteoarthritis. The aim of this study was to analyse the effects of nifedipine on metabolic processes in human chondrocytes and bone marrow mesenchymal stem cells. To better understand whether the metabolic effects are mediated specifically through L-type voltage-operated calcium channel, effects of the agonist BayK8644 were analyzed in parallel. Nifedipine downregulated and mitochondrial respiration and ATP production in both cell types. Analysis of cartilage explants by electron microscopy also suggested that a small number of chondrocyte mitochondria's lose their activity in response to nifedipine. Conversely, nifedipine enhanced glycolytic capacity in chondrocytes, suggesting that these cells have the capacity to switch from oxidative phosphorylation to glycolysis and alter their metabolic activity in response to L-type voltage-operated calcium channel inhibition. Such a metabolic switch was not observed in bone marrow mesenchymal stem cells. Nitric oxide activity was upregulated by nifedipine in bone marrow mesenchymal stem cells and particularly in chondrocytes, implying its involvement in the effects of nifedipine on metabolism in both tested cell types. Furthermore, stimulation with nifedipine resulted in elevated production of collagen type II and glycosaminoglycans in micromass cultures under chondrogenic conditions. Taken together, we conclude that the antihypertensive drug nifedipine inhibits mitochondrial respiration in both chondrocytes and bone marrow mesenchymal stem cells and that these effects may be associated with the increased nitric oxide accumulation and pro-inflammatory activity. Nifedipine had positive effects on the production of collagen type II and proteoglycans in both cell types, implying potentially beneficial anabolic responses in articular cartilage. These results highlight a potential link between antihypertensive drugs and cartilage health. Frontiers Media S.A. 2019-11-08 /pmc/articles/PMC6857108/ /pubmed/31781032 http://dx.doi.org/10.3389/fendo.2019.00756 Text en Copyright © 2019 Uzieliene, Bernotiene, Rakauskiene, Denkovskij, Bagdonas, Mackiewicz, Porvaneckas, Kvederas and Mobasheri. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Uzieliene, Ilona Bernotiene, Eiva Rakauskiene, Greta Denkovskij, Jaroslav Bagdonas, Edvardas Mackiewicz, Zygmunt Porvaneckas, Narunas Kvederas, Giedrius Mobasheri, Ali The Antihypertensive Drug Nifedipine Modulates the Metabolism of Chondrocytes and Human Bone Marrow-Derived Mesenchymal Stem Cells |
title | The Antihypertensive Drug Nifedipine Modulates the Metabolism of Chondrocytes and Human Bone Marrow-Derived Mesenchymal Stem Cells |
title_full | The Antihypertensive Drug Nifedipine Modulates the Metabolism of Chondrocytes and Human Bone Marrow-Derived Mesenchymal Stem Cells |
title_fullStr | The Antihypertensive Drug Nifedipine Modulates the Metabolism of Chondrocytes and Human Bone Marrow-Derived Mesenchymal Stem Cells |
title_full_unstemmed | The Antihypertensive Drug Nifedipine Modulates the Metabolism of Chondrocytes and Human Bone Marrow-Derived Mesenchymal Stem Cells |
title_short | The Antihypertensive Drug Nifedipine Modulates the Metabolism of Chondrocytes and Human Bone Marrow-Derived Mesenchymal Stem Cells |
title_sort | antihypertensive drug nifedipine modulates the metabolism of chondrocytes and human bone marrow-derived mesenchymal stem cells |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857108/ https://www.ncbi.nlm.nih.gov/pubmed/31781032 http://dx.doi.org/10.3389/fendo.2019.00756 |
work_keys_str_mv | AT uzielieneilona theantihypertensivedrugnifedipinemodulatesthemetabolismofchondrocytesandhumanbonemarrowderivedmesenchymalstemcells AT bernotieneeiva theantihypertensivedrugnifedipinemodulatesthemetabolismofchondrocytesandhumanbonemarrowderivedmesenchymalstemcells AT rakauskienegreta theantihypertensivedrugnifedipinemodulatesthemetabolismofchondrocytesandhumanbonemarrowderivedmesenchymalstemcells AT denkovskijjaroslav theantihypertensivedrugnifedipinemodulatesthemetabolismofchondrocytesandhumanbonemarrowderivedmesenchymalstemcells AT bagdonasedvardas theantihypertensivedrugnifedipinemodulatesthemetabolismofchondrocytesandhumanbonemarrowderivedmesenchymalstemcells AT mackiewiczzygmunt theantihypertensivedrugnifedipinemodulatesthemetabolismofchondrocytesandhumanbonemarrowderivedmesenchymalstemcells AT porvaneckasnarunas theantihypertensivedrugnifedipinemodulatesthemetabolismofchondrocytesandhumanbonemarrowderivedmesenchymalstemcells AT kvederasgiedrius theantihypertensivedrugnifedipinemodulatesthemetabolismofchondrocytesandhumanbonemarrowderivedmesenchymalstemcells AT mobasheriali theantihypertensivedrugnifedipinemodulatesthemetabolismofchondrocytesandhumanbonemarrowderivedmesenchymalstemcells AT uzielieneilona antihypertensivedrugnifedipinemodulatesthemetabolismofchondrocytesandhumanbonemarrowderivedmesenchymalstemcells AT bernotieneeiva antihypertensivedrugnifedipinemodulatesthemetabolismofchondrocytesandhumanbonemarrowderivedmesenchymalstemcells AT rakauskienegreta antihypertensivedrugnifedipinemodulatesthemetabolismofchondrocytesandhumanbonemarrowderivedmesenchymalstemcells AT denkovskijjaroslav antihypertensivedrugnifedipinemodulatesthemetabolismofchondrocytesandhumanbonemarrowderivedmesenchymalstemcells AT bagdonasedvardas antihypertensivedrugnifedipinemodulatesthemetabolismofchondrocytesandhumanbonemarrowderivedmesenchymalstemcells AT mackiewiczzygmunt antihypertensivedrugnifedipinemodulatesthemetabolismofchondrocytesandhumanbonemarrowderivedmesenchymalstemcells AT porvaneckasnarunas antihypertensivedrugnifedipinemodulatesthemetabolismofchondrocytesandhumanbonemarrowderivedmesenchymalstemcells AT kvederasgiedrius antihypertensivedrugnifedipinemodulatesthemetabolismofchondrocytesandhumanbonemarrowderivedmesenchymalstemcells AT mobasheriali antihypertensivedrugnifedipinemodulatesthemetabolismofchondrocytesandhumanbonemarrowderivedmesenchymalstemcells |